Talene A. Yacoubian, Ph.D.

Duke University, Durham, NC 
"Talene Yacoubian"
Mean distance: 22899.9


Sign in to add mentor
Donald C. Lo grad student 2000 Duke
 (Differential regulation of dendritic growth by the TrkB neurotrophin receptor isoforms.)
David G. Standaert post-doc 2005-2007 Harvard Medical School
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Apetauerova D, Scala SA, Hamill RW, et al. (2016) CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial. Neurology® Neuroimmunology & Neuroinflammation. 3: e266
Lavalley NJ, Slone SR, Ding H, et al. (2015) 14-3-3 proteins regulate mutant LRRK2 kinase activity and neurite shortening. Human Molecular Genetics
Yacoubian TA, Standaert DG. (2014) Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 306
Fraser KB, Moehle MS, Daher JP, et al. (2013) LRRK2 secretion in exosomes is regulated by 14-3-3. Human Molecular Genetics. 22: 4988-5000
Steidinger TU, Slone SR, Ding H, et al. (2013) Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice. Plos One. 8: e56092
Harrington AJ, Yacoubian TA, Slone SR, et al. (2012) Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2142-53
Lee YJ, Wang S, Slone SR, et al. (2011) Defects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease. Plos One. 6: e15946
Steidinger TU, Standaert DG, Yacoubian TA. (2011) A neuroprotective role for angiogenin in models of Parkinson's disease. Journal of Neurochemistry. 116: 334-41
Yacoubian TA, Slone SR, Harrington AJ, et al. (2010) Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2
Standaert DG, Yacoubian TA. (2010) Target validation: the Parkinson disease perspective. Disease Models & Mechanisms. 3: 259-62
See more...